BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.800
+0.060 (1.27%)
At close: Aug 28, 2025, 4:00 PM
4.850
+0.050 (1.04%)
After-hours: Aug 28, 2025, 4:55 PM EDT

BioAge Labs Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
2519.1614.519.45
Research & Development
59.0459.0433.8930.52
Operating Expenses
84.0378.1948.439.97
Operating Income
-91.33-78.19-48.4-39.97
Interest Expense
-1.16-2.37-7.79-0.24
Interest & Investment Income
13.279.632.430.47
EBT Excluding Unusual Items
-79.1-70.93-53.76-39.75
Other Unusual Items
0.07-0.18-10.090.02
Pretax Income
-79.03-71.11-63.85-39.72
Net Income
-79.03-71.11-63.85-39.72
Net Income to Common
-79.03-71.11-63.85-39.72
Shares Outstanding (Basic)
281122
Shares Outstanding (Diluted)
281122
Shares Change (YoY)
1552.56%541.23%0.06%-
EPS (Basic)
-2.84-6.63-38.17-23.76
EPS (Diluted)
-2.84-6.63-38.17-23.76
Free Cash Flow
-58.32-51.89-37.53-36.28
Free Cash Flow Per Share
-2.10-4.84-22.43-21.70
EBITDA
-91.15-78.03-48.24-39.84
D&A For EBITDA
0.180.170.160.13
EBIT
-91.33-78.19-48.4-39.97
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q